{"title":"揭开埃文斯综合征的面纱:席姆克免疫骨发育不良症的罕见表现","authors":"Swathi Krishna, Purva Kanvinde, Ritika Khurana, Minnie Bodhanwala, Sangeeta Mudaliar","doi":"10.1016/j.phoj.2024.08.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Evans syndrome is an autoimmune condition that manifests as two or more autoimmune cytopenia. We present a case of Evans syndrome diagnosed with an underlying skeletal dysplasia; Schimke immune-osseous dysplasia (SIOD). The condition is characterized by spondyloepiphyseal dysplasia, progressive nephropathy, and T-cell immunodeficiency with cytopenia. Notably, our patient did not exhibit any signs of renal involvement.</p></div><div><h3>Case report</h3><p>A five-and-a-half-year-old female child presented with a short history of bleeding manifestations along with a history of poor weight and height gain. She was subsequently diagnosed with Evans syndrome secondary to an underlying SMARCAL1 mutation, which could be well controlled with oral steroids.</p></div><div><h3>Conclusion</h3><p>SIOD is a rare multisystem disorder affecting the skeletal, renal, immune, and vascular systems. Autoimmune cytopenia was the chief presentation of our patient. Such entities should be suspected in patients with growth failure, bone deformities, and hematological involvement. Early genetic testing will help to reduce disease-related comorbidities and aid in rationalizing treatment strategies.</p></div>","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 4","pages":"Pages 250-254"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468124524000652/pdfft?md5=329bfa59485f181b7f3426969d2b1d7d&pid=1-s2.0-S2468124524000652-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Unmasking Evans syndrome: A rare presentation of Schimke immune-osseous dysplasia\",\"authors\":\"Swathi Krishna, Purva Kanvinde, Ritika Khurana, Minnie Bodhanwala, Sangeeta Mudaliar\",\"doi\":\"10.1016/j.phoj.2024.08.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Evans syndrome is an autoimmune condition that manifests as two or more autoimmune cytopenia. We present a case of Evans syndrome diagnosed with an underlying skeletal dysplasia; Schimke immune-osseous dysplasia (SIOD). The condition is characterized by spondyloepiphyseal dysplasia, progressive nephropathy, and T-cell immunodeficiency with cytopenia. Notably, our patient did not exhibit any signs of renal involvement.</p></div><div><h3>Case report</h3><p>A five-and-a-half-year-old female child presented with a short history of bleeding manifestations along with a history of poor weight and height gain. She was subsequently diagnosed with Evans syndrome secondary to an underlying SMARCAL1 mutation, which could be well controlled with oral steroids.</p></div><div><h3>Conclusion</h3><p>SIOD is a rare multisystem disorder affecting the skeletal, renal, immune, and vascular systems. Autoimmune cytopenia was the chief presentation of our patient. Such entities should be suspected in patients with growth failure, bone deformities, and hematological involvement. Early genetic testing will help to reduce disease-related comorbidities and aid in rationalizing treatment strategies.</p></div>\",\"PeriodicalId\":101004,\"journal\":{\"name\":\"Pediatric Hematology Oncology Journal\",\"volume\":\"9 4\",\"pages\":\"Pages 250-254\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2468124524000652/pdfft?md5=329bfa59485f181b7f3426969d2b1d7d&pid=1-s2.0-S2468124524000652-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Hematology Oncology Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2468124524000652\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Hematology Oncology Journal","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468124524000652","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景埃文斯综合征是一种自身免疫性疾病,表现为两种或两种以上自身免疫性全血细胞减少症。我们介绍了一例埃文斯综合征病例,该病例被诊断为潜在的骨骼发育不良;Schimke 免疫骨发育不良(SIOD)。该病症的特点是脊柱骺发育不良、进行性肾病和伴有全血细胞减少的 T 细胞免疫缺陷。值得注意的是,我们的患者并没有表现出任何肾脏受累的迹象。病例报告一名五岁半的女婴出现了短暂的出血表现,同时伴有体重和身高增长不良的病史。随后,她被诊断为继发于 SMARCAL1 基因突变的埃文斯综合征,口服类固醇可以很好地控制病情。自身免疫性全血细胞减少症是本例患者的主要表现。如果患者出现生长迟缓、骨骼畸形和血液系统受累,则应怀疑此类疾病。早期基因检测将有助于减少与疾病相关的并发症,并有助于治疗策略的合理化。
Unmasking Evans syndrome: A rare presentation of Schimke immune-osseous dysplasia
Background
Evans syndrome is an autoimmune condition that manifests as two or more autoimmune cytopenia. We present a case of Evans syndrome diagnosed with an underlying skeletal dysplasia; Schimke immune-osseous dysplasia (SIOD). The condition is characterized by spondyloepiphyseal dysplasia, progressive nephropathy, and T-cell immunodeficiency with cytopenia. Notably, our patient did not exhibit any signs of renal involvement.
Case report
A five-and-a-half-year-old female child presented with a short history of bleeding manifestations along with a history of poor weight and height gain. She was subsequently diagnosed with Evans syndrome secondary to an underlying SMARCAL1 mutation, which could be well controlled with oral steroids.
Conclusion
SIOD is a rare multisystem disorder affecting the skeletal, renal, immune, and vascular systems. Autoimmune cytopenia was the chief presentation of our patient. Such entities should be suspected in patients with growth failure, bone deformities, and hematological involvement. Early genetic testing will help to reduce disease-related comorbidities and aid in rationalizing treatment strategies.